DK1600510T3 - DNA-sekvenser med antirepressoraktivitet - Google Patents

DNA-sekvenser med antirepressoraktivitet

Info

Publication number
DK1600510T3
DK1600510T3 DK05076209T DK05076209T DK1600510T3 DK 1600510 T3 DK1600510 T3 DK 1600510T3 DK 05076209 T DK05076209 T DK 05076209T DK 05076209 T DK05076209 T DK 05076209T DK 1600510 T3 DK1600510 T3 DK 1600510T3
Authority
DK
Denmark
Prior art keywords
antirepressant
activity
dna sequences
regulatory sequences
provides
Prior art date
Application number
DK05076209T
Other languages
English (en)
Inventor
Arie Pieter Otte
Arthur Leo Kruckeberg
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01202581A external-priority patent/EP1273666A1/en
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Application granted granted Critical
Publication of DK1600510T3 publication Critical patent/DK1600510T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK05076209T 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet DK1600510T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01202581A EP1273666A1 (en) 2001-07-04 2001-07-04 Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US30319901P 2001-07-05 2001-07-05
PCT/NL2002/000390 WO2003004704A2 (en) 2001-07-04 2002-06-14 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US10/190,312 US7192741B2 (en) 2001-07-04 2002-07-05 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences

Publications (1)

Publication Number Publication Date
DK1600510T3 true DK1600510T3 (da) 2007-06-25

Family

ID=47915807

Family Applications (8)

Application Number Title Priority Date Filing Date
DK06124470.3T DK1806407T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124491.9T DK1842919T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet
DK02741531T DK1404872T3 (da) 2001-07-04 2002-06-14 Fremgangsmåde til selektion af en DNA-sekvens med transkriptionsmodulerende aktivitet med en vektor indeholdende et element med en gentranskriptionsundertrykkende aktivitet
DK06124481.0T DK1845162T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK05076209T DK1600510T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet
DK06124482.8T DK1829972T3 (da) 2001-07-04 2002-06-14 DNA-Sekvenser med anti-repressoraktivitet
DK06124465.3T DK1808488T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124475.2T DK1829971T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet

Family Applications Before (4)

Application Number Title Priority Date Filing Date
DK06124470.3T DK1806407T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124491.9T DK1842919T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet
DK02741531T DK1404872T3 (da) 2001-07-04 2002-06-14 Fremgangsmåde til selektion af en DNA-sekvens med transkriptionsmodulerende aktivitet med en vektor indeholdende et element med en gentranskriptionsundertrykkende aktivitet
DK06124481.0T DK1845162T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK06124482.8T DK1829972T3 (da) 2001-07-04 2002-06-14 DNA-Sekvenser med anti-repressoraktivitet
DK06124465.3T DK1808488T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124475.2T DK1829971T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet

Country Status (21)

Country Link
US (9) US7192741B2 (da)
EP (8) EP1600510B1 (da)
JP (3) JP4500044B2 (da)
KR (2) KR100942117B1 (da)
CN (1) CN1266282C (da)
AT (8) ATE474053T1 (da)
AU (3) AU2002314629B2 (da)
BR (1) BRPI0210771B8 (da)
CA (2) CA2450020C (da)
CY (1) CY1107678T1 (da)
DE (8) DE60236331D1 (da)
DK (8) DK1806407T3 (da)
ES (8) ES2344070T3 (da)
IL (4) IL159674A0 (da)
MX (1) MXPA03011801A (da)
NO (1) NO338477B1 (da)
NZ (1) NZ530218A (da)
PT (1) PT1600510E (da)
SG (1) SG143066A1 (da)
WO (1) WO2003004704A2 (da)
ZA (1) ZA200309599B (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2344070T3 (es) 2001-07-04 2010-08-17 Chromagenics B.V. Secuencias de adn con actividad anti-represora.
NZ537073A (en) 2002-06-14 2006-08-31 Chromagenics B A method for simultaneous production of multiple proteins; vectors and cells for use therein
AU2003243059A1 (en) 2002-06-14 2003-12-31 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
PT2314629E (pt) 2002-07-18 2014-01-22 Merus B V Produção recombinante de misturas de anticorpos
ES2373549T3 (es) 2002-12-18 2012-02-06 Chromagenics B.V. Método para mejorar la producción de proteínas.
AU2003290453A1 (en) 2002-12-20 2004-07-14 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
EP2395016A3 (en) 2003-05-30 2012-12-19 Merus B.V. Design and use of paired variable regions of specific binding molecules
SI1670925T1 (sl) 2003-10-02 2013-10-30 Crucell Holland B.V. Pakirne celice za rekombinantni adenovirus
WO2005059149A2 (en) * 2003-12-12 2005-06-30 Chromagenics B.V. Improved protein production
JP5912211B2 (ja) 2004-01-20 2016-04-27 メルス ビー．ヴィー． 結合タンパク質の混合物
CA2573022C (en) * 2004-07-08 2012-03-06 Chromagenics B.V. Novel sequence for improving expression of nucleic acid
ATE459720T1 (de) * 2004-08-18 2010-03-15 Bayer Cropscience Ag Pflanzen mit erhöhter plastidär aktivität der stärkephosphorylierenden r3-enzyme
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
AU2005300503B2 (en) 2004-11-08 2010-12-16 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) * 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060172382A1 (en) * 2004-11-08 2006-08-03 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
DE602005027738D1 (de) * 2004-11-18 2011-06-09 Univ Hiroshima Nat Univ Corp Verfahren und kit zur expression von protein unter regulation der expression von einer durch genamplifikation gebildeten wiederholungssequenz und transformant
US7968700B2 (en) 2006-03-20 2011-06-28 Chromagenics B.V. Expression augmenting DNA fragments, use thereof, and methods for finding thereof
US20080124760A1 (en) 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
CN101627123A (zh) * 2007-01-08 2010-01-13 米利波尔公司 消除基因扩增的高表达细胞系
US9284563B2 (en) 2009-06-15 2016-03-15 Cellagenics B.V. Stringent selectable markers
US8566596B2 (en) 2010-08-24 2013-10-22 Cisco Technology, Inc. Pre-association mechanism to provide detailed description of wireless services
DK2611915T3 (da) 2010-09-01 2015-06-22 Cellagenics B V Nukleinsyrefragmenter fra en ribosomal proteinpromoter til forstærkning af genekspression
DK2838917T3 (da) 2012-04-20 2019-08-26 Merus Nv Fremgangsmåder og midler til frembringelse af heterodimere ig-lignende molekyler
AU2013285355A1 (en) 2012-07-06 2015-01-29 Genmab B.V. Dimeric protein with triple mutations
HRP20181717T1 (hr) 2012-09-27 2018-12-28 Merus N.V. Bispecifična igg protutijela kao aktivatori t stanice
US10417380B1 (en) 2013-12-31 2019-09-17 Mckesson Corporation Systems and methods for determining and communicating a prescription benefit coverage denial to a prescriber
US10489552B2 (en) 2014-02-14 2019-11-26 Mckesson Corporation Systems and methods for determining and communicating patient incentive information to a prescriber
ES2816624T3 (es) 2014-02-28 2021-04-05 Merus Nv Anticuerpos que se unen a EGFR y ERBB3
HRP20250041T1 (hr) 2014-02-28 2025-03-14 Merus N.V. Antitijelo koje veže erbb-2 i erbb-3
US10157262B1 (en) 2015-03-10 2018-12-18 Mckesson Corporation Systems and methods for determining patient financial responsibility for multiple prescription products
ES2693596T3 (es) 2015-07-10 2018-12-12 Merus N.V. Anticuerpo que se une a CD3 humano
KR20250157457A (ko) 2015-10-23 2025-11-04 메뤼스 엔.페. 암 성장을 억제하는 결합 분자
US11514137B1 (en) 2016-03-30 2022-11-29 Mckesson Corporation Alternative therapy identification system
US10999224B1 (en) 2017-02-01 2021-05-04 Mckesson Corporation Method and apparatus for parsing an electronic message and constructing multiple differently prioritized messages therefrom
WO2018182422A1 (en) 2017-03-31 2018-10-04 Merus N.V. Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene
CN111148764B (zh) 2017-05-17 2025-08-12 美勒斯公司 用于乳腺癌的ErbB-2/ErbB-3双特异性抗体与内分泌治疗的组合
PL3665198T3 (pl) 2017-08-09 2025-06-09 Merus N.V. Przeciwciała wiążące egfr i cmet
US10862832B1 (en) 2018-07-24 2020-12-08 Mckesson Corporation Computing system and method for automatically reversing an action indicated by an electronic message
US11043437B2 (en) 2019-01-07 2021-06-22 Applied Materials, Inc. Transparent substrate with light blocking edge exclusion zone
US11562437B1 (en) 2019-06-26 2023-01-24 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
US12525327B1 (en) 2019-06-26 2026-01-13 Mckesson Corporation Method, apparatus, and computer program product for providing real-time pricing information
US12469040B1 (en) 2019-06-26 2025-11-11 Mckesson Corporation Method, apparatus, and computer program product for providing real-time pricing information
US11636548B1 (en) 2019-06-26 2023-04-25 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
EP3772518A1 (en) 2019-08-07 2021-02-10 Merus N.V. Modified human variable domains
US20230104317A1 (en) * 2020-01-31 2023-04-06 The Board Of Trustees Of The Leland Stanford Junior University Systems and Methods to Identify Genetic Silencers and Applications Thereof
US11610240B1 (en) 2020-02-17 2023-03-21 Mckesson Corporation Method, apparatus, and computer program product for partitioning prescription transaction costs in an electronic prescription transaction
US12229834B1 (en) 2020-02-17 2025-02-18 Mckesson Corporation Method, apparatus, and computer program product for partitioning prescription transaction costs in an electronic prescription transaction
US12229833B1 (en) 2020-02-17 2025-02-18 Mckesson Corporation Method, apparatus, and computer program product for reformatting an electronic prescription transaction
CA3175227A1 (en) 2020-05-21 2021-11-25 Cornelis De Kruif Methods and means for the production of ig-like molecules
US11587657B2 (en) 2020-09-04 2023-02-21 Mckesson Corporation Method, apparatus, and computer program product for performing an alternative evaluation procedure in response to an electronic message
US12367954B1 (en) 2021-01-08 2025-07-22 Mckesson Corporation Method, apparatus, and computer program product for estimating a target quantitative measure based upon historical electronic messages
US12518304B1 (en) 2021-01-26 2026-01-06 Mckesson Corporation Method, apparatus, and computer program product for estimating a target quantitative measure based upon historical electronic messages
CN113539357B (zh) * 2021-06-10 2024-04-30 阿里巴巴达摩院(杭州)科技有限公司 基因检测方法、模型训练方法、装置、设备及系统
US12197972B1 (en) 2022-03-28 2025-01-14 Mckesson Corporation Method, apparatus, and computer program product for generating alternative evaluation messages

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US719271A (en) * 1902-01-13 1903-01-27 Solomon P Smith Furnace.
US5610053A (en) 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5972605A (en) * 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
CA2216428A1 (en) * 1995-03-24 1996-10-03 Shionogi & Co., Ltd. Dna molecule relating to suppression of gene expression and novel protein
DE19539493A1 (de) * 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US6037525A (en) * 1996-08-01 2000-03-14 North Carolina State University Method for reducing expression variability of transgenes in plant cells
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
JP4220673B2 (ja) 1998-07-21 2009-02-04 ミリポア・コーポレイション 遍在性クロマチンオープニングエレメント（ｕｃｏｅ）を含むポリヌクレオチド
EP1104490B8 (en) 1998-08-14 2008-02-13 Chromagenics B.V. Method of detecting a dna sequence, a dna sequence, a method of making a dna construct and the use thereof
US6800457B2 (en) 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6521419B1 (en) 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6395549B1 (en) 1998-10-22 2002-05-28 Medical College Of Georgia Research Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
ATE342962T1 (de) * 1999-08-25 2006-11-15 Immunex Corp Zusammensetzungen und verfahren für verbesserte zellkultur
US6586205B1 (en) 2000-02-11 2003-07-01 Millennium Pharmaceuticals, Inc. 43239 a novel GPCR-like molecule and uses thereof
US20030166042A1 (en) 2000-02-11 2003-09-04 Millennium Pharmaceuticals, Inc. Novel seven-transmembrane proteins/G-protein coupled receptors
AU9006701A (en) 2000-09-20 2002-04-02 Cobra Therapeutics Ltd Polynucleotide
ES2344070T3 (es) 2001-07-04 2010-08-17 Chromagenics B.V. Secuencias de adn con actividad anti-represora.
EP1273666A1 (en) 2001-07-04 2003-01-08 Chromagenics B.V. Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
AU2003243059A1 (en) 2002-06-14 2003-12-31 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
NZ537073A (en) * 2002-06-14 2006-08-31 Chromagenics B A method for simultaneous production of multiple proteins; vectors and cells for use therein
ES2373549T3 (es) 2002-12-18 2012-02-06 Chromagenics B.V. Método para mejorar la producción de proteínas.
AU2003290453A1 (en) 2002-12-20 2004-07-14 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors

Also Published As

Publication number Publication date
DE60215502D1 (de) 2006-11-30
DE60236334D1 (de) 2010-06-17
US20070026499A1 (en) 2007-02-01
ES2344070T3 (es) 2010-08-17
ES2344071T3 (es) 2010-08-17
EP1829972A2 (en) 2007-09-05
DE60236332D1 (de) 2010-06-17
CA2450020A1 (en) 2003-01-16
EP1600510A2 (en) 2005-11-30
EP1808488A3 (en) 2007-11-14
IL159674A0 (en) 2004-06-20
SG143066A1 (en) 2008-06-27
US7951586B2 (en) 2011-05-31
EP1404872A2 (en) 2004-04-07
ATE358183T1 (de) 2007-04-15
EP1806407B1 (en) 2010-05-05
US20070031935A1 (en) 2007-02-08
DE60237048D1 (de) 2010-08-26
KR100942117B1 (ko) 2010-02-12
CN1266282C (zh) 2006-07-26
DK1845162T3 (da) 2010-08-16
CA2812799C (en) 2016-01-26
EP1829971A1 (en) 2007-09-05
EP1845162A1 (en) 2007-10-17
KR100942116B1 (ko) 2010-02-12
ES2274045T3 (es) 2007-05-16
CY1107678T1 (el) 2013-04-18
NO338477B1 (no) 2016-08-22
DK1829972T3 (da) 2010-09-13
DE60219221D1 (de) 2007-05-10
KR20090037960A (ko) 2009-04-16
EP1842919A1 (en) 2007-10-10
PT1600510E (pt) 2007-06-25
DE60236333D1 (de) 2010-06-17
IL193374A (en) 2010-12-30
DK1806407T3 (da) 2010-08-16
EP1845162B1 (en) 2010-05-05
ATE466941T1 (de) 2010-05-15
US20070031933A1 (en) 2007-02-08
ES2344072T3 (es) 2010-08-17
EP1404872B1 (en) 2006-10-18
NO20040011L (no) 2004-03-03
US7736869B2 (en) 2010-06-15
BR0210771A (pt) 2004-07-13
US7655441B2 (en) 2010-02-02
NZ530218A (en) 2005-09-30
ES2285630T3 (es) 2007-11-16
JP2010131024A (ja) 2010-06-17
US20030199468A1 (en) 2003-10-23
CN1524128A (zh) 2004-08-25
EP1600510A3 (en) 2006-02-22
ATE466942T1 (de) 2010-05-15
AU2011202193A1 (en) 2011-06-02
EP1806407A2 (en) 2007-07-11
ATE466943T1 (de) 2010-05-15
JP5014443B2 (ja) 2012-08-29
KR20090037485A (ko) 2009-04-15
EP1806407A3 (en) 2008-06-04
IL159674A (en) 2009-02-11
US7736868B2 (en) 2010-06-15
US7659094B2 (en) 2010-02-09
DE60215502T2 (de) 2007-08-30
DE60236331D1 (de) 2010-06-17
EP1829971A3 (en) 2008-06-04
CA2450020C (en) 2013-08-13
ES2344073T3 (es) 2010-08-17
DE60219221T2 (de) 2008-01-03
US20070128717A1 (en) 2007-06-07
BRPI0210771B1 (pt) 2015-12-22
US20070037256A1 (en) 2007-02-15
IL193373A (en) 2010-12-30
AU2007234619B2 (en) 2011-06-02
AU2011202193B2 (en) 2011-09-29
EP1808488B1 (en) 2010-07-14
US7749733B2 (en) 2010-07-06
ES2348174T3 (es) 2010-11-30
JP2010131025A (ja) 2010-06-17
BRPI0210771B8 (pt) 2021-05-25
DE60236379D1 (de) 2010-06-24
CA2812799A1 (en) 2003-01-16
EP1808488A2 (en) 2007-07-18
EP1829972B1 (en) 2010-05-12
US20070031936A1 (en) 2007-02-08
EP1842919B1 (en) 2010-05-05
DK1842919T3 (da) 2010-08-16
JP5014444B2 (ja) 2012-08-29
US7662591B2 (en) 2010-02-16
ES2344074T3 (es) 2010-08-17
ATE474053T1 (de) 2010-07-15
EP1600510B1 (en) 2007-03-28
WO2003004704A3 (en) 2003-10-16
HK1068652A1 (en) 2005-04-29
AU2002314629B2 (en) 2007-08-30
US7736870B2 (en) 2010-06-15
EP1829971B1 (en) 2010-05-05
US20070026498A1 (en) 2007-02-01
DK1808488T3 (da) 2010-10-18
JP2004533262A (ja) 2004-11-04
ATE343004T1 (de) 2006-11-15
ZA200309599B (en) 2006-05-31
ATE466944T1 (de) 2010-05-15
WO2003004704A2 (en) 2003-01-16
US20070031934A1 (en) 2007-02-08
EP1829972A3 (en) 2007-10-24
DK1404872T3 (da) 2007-02-19
JP4500044B2 (ja) 2010-07-14
DK1829971T3 (da) 2010-08-16
ATE467682T1 (de) 2010-05-15
US7192741B2 (en) 2007-03-20
AU2007234619A1 (en) 2007-12-13
MXPA03011801A (es) 2005-03-07

Similar Documents

Publication Publication Date Title
DK1842919T3 (da) DNA-sekvenser med antirepressoraktivitet
CY1108211T1 (el) Προφυλακτικη και θεραπευτικη αγωγη των μολυσματικων, αυτοανοσων και αλλεργικων νοσων με ενωσεις βασης μονοσακχαριτη
ATE542801T1 (de) Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
DE60325189D1 (de) Wasserfilter
DE69636511D1 (de) Amplifikation von einfachen sequenz wiederholungen
DE60214080D1 (de) Medizinische Verwendung thyromimetischer Verbindungen gegen Haarausfall und Zusammensetzungen
DE502004012196D1 (de) Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen
ATE310392T1 (de) Verwendung von oxytocin zur stimulierung des pflanzenwachstums
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
Jozsef Poisonings of animal origin Review article. 3. Poisonings by Arthropoda. 2. Arachnida
DE50203158D1 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose
ITGE20040063A1 (it) Metodo per incrementare l'efficacia biologica dei campi elettromagnetici usati per il trattamento di esseri umani animali o piante.
ATE480638T1 (de) Nukleinsäuremoleküle aus peritrophin von flöhen, proteine und ihre anwendungen